Novo Nordisk | pharmaphorum

Friday 24 July 2026

Novo Nordisk

News

Novo Nordisk HQ flag hires

Novo Nordisk looking at M&A to revive fortunes, says CEO

Novo Nordisk’s new CEO Lars Fruergaard Joergensen says it is considering M&A to shore up performance as its key US diabetes sales come under pressure.

News

Jacob_Riis

After missing out on CEO job, Novo's US head quits

The pressure on Novo Nordisk's diabetes portfolio is mounting in the US - and the situation seems even more precarious after its top exec in the region quit.

News

Novo Nordisk HQ flag hires

Novo completes major filings for blockbuster hope semaglutid...

Novo Nordisk has its weekly diabetes hopeful semaglutide filed in five key markets, after submitting a dossier in Japan.

News

Roche Rituxan approval

Patient death raises concerns over Roche haemophilia drug

Concerns following event on HAVEN1 trial.

News

French pharma company Sanofi

Sanofi diabetes combo approved in EU

Drug will compete against Novo Nordisk's Xultophy.

News

Pfizer, Novo invest in Swedish patient stratification startup

Pfizer, Novo invest in Swedish patient stratification startu...

Funds will go towards development of AMRA's body composition profiling tool AMRA Profiler.